Development of self-microemulsifying drug delivery system for oral bioavailability enhancement of berberine hydrochloride

Drug Development and Industrial Pharmacy
Jia-Xiao ZhuQuan Zhu

Abstract

The purpose of this study was to develop a self-microemulsifying drug delivery system (SMEDDS) to improve the oral bioavailability of Berberine hydrochloride (BBH), an important bioactive compound from Chinese Medicines with poor water solubility. Pseudoternary phase diagrams were constructed using oil, surfactant and co-surfactant types to identify the efficient self-microemulsification region. SMEDDS was characterized by morphological observation, droplet size, zeta-potential determination, stability, in vitro release and in vivo bioavailability study. The optimal formulation with the best self-microemulsifying and solubilization ability consisted of 40% (w/w) of ethyl linoleate and oleic acid (2:1), 35% (w/w) Tween-80 and 25% (w/w) glycerol. The SMEDDS of BBH could exhibit good stability. In vitro release test showed a complete release of BBH from SMEDDS was in 5 h. In vivo results indicated that the peak plasma concentration (C(max)) and the area under the curve (AUC(0→12 h)) of SMEDDS of BBH were higher than the commercial tablet by 163.4% and 154.2%, respectively. The relative bioavailability of SMEDDS of BBH was enhanced about 2.42-fold compared with the commercial tablet in rats. The study confirmed that the SMEDDS form...Continue Reading

References

Mar 29, 2000·Journal of Pharmaceutical Sciences·B J Aungst
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·C W Pouton
Mar 17, 2001·Advanced Drug Delivery Reviews·S SakumaM Akashi
Mar 17, 2001·Advanced Drug Delivery Reviews·K A JanesM J Alonso
May 31, 2002·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Caitriona M O'Driscoll
Mar 20, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jeff WangWei-Chiang Shen
Mar 11, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Wei WuLi Que
Apr 14, 2006·Current Drug Delivery·P K Ghosh, R S R Murthy
May 3, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Mette GroveGitte Pommergaard Pedersen
Nov 28, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Sheikh ShafiqMushir Ali
Aug 8, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Chang-Hsien LeeTin-Yun Ho
Feb 5, 2008·International Journal of Pharmaceutics·Ping ZhangJie Xu
Dec 2, 2008·Drug Development and Industrial Pharmacy·Shu-Xia CuiJian-Ping Sun
Jan 7, 2009·International Journal of Pharmaceutics·Jing CuiGuangxi Zhai
May 19, 2009·International Journal of Pharmaceutics·Prabagar BalakrishnanHan-Gon Choi
Feb 9, 2010·Drug Development and Industrial Pharmacy·Gantala VenkateshV Navaratnam
Aug 27, 2010·Drug Development and Industrial Pharmacy·Xuemei WuCaixia Wen
Mar 5, 2011·Journal of Pharmaceutical Sciences·Zhengqi DongAkira Yamamoto
May 28, 2011·Drug Development and Industrial Pharmacy·Yongjun WangZhonggui He
Sep 21, 2011·International Journal of Nanomedicine·Wen TanYitao Wang

❮ Previous
Next ❯

Citations

Nov 2, 2013·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Swati PundGanesh Rasve
Nov 19, 2013·Drug Development and Industrial Pharmacy·Nguyen Duc HanhNuttanan Sinchaipanid
Feb 7, 2016·Fitoterapia·Chang-Shun LiuXiao-Ying Long
May 3, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Prakash C SenapatiAlakh N Sahu
Apr 14, 2015·Evidence-based Complementary and Alternative Medicine : ECAM·Zhiping WangTongsheng Chen
May 11, 2015·International Journal of Pharmaceutics·Qiuping LiQing Wu
Sep 30, 2016·Drug Delivery·Bappaditya ChatterjeePinaki Sengupta
Oct 30, 2016·British Journal of Pharmacology·Antonello Santini, Ettore Novellino
Feb 23, 2019·Journal of Separation Science·Jiahui WangNing Zhang
Jun 20, 2019·Recent Patents on Nanotechnology·Dilpreet SinghNeena Bedi
May 2, 2019·Nature Communications·Hui-Hui GuoJian-Dong Jiang
Jan 9, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Tong XuGang Fan
Nov 14, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xinmei XuGang Fan
Jun 1, 2021·Phytotherapy Research : PTR·Sapana BansodChandraiah Godugu
Aug 4, 2021·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Oi Jin TanUsha Sundralingam
Aug 31, 2021·Expert Opinion on Therapeutic Patents·Yuan KongDong-Dong Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences
Urvashi GoyalGeeta Aggarwal
© 2021 Meta ULC. All rights reserved